Literature DB >> 33674264

Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab.

Marcia A Friedman1, Kevin L Winthrop2,3.   

Abstract

Entities:  

Keywords:  Covid-19; granulomatosis with polyangiitis; rituximab

Mesh：

Substances：

Year:  2021        PMID： 33674264      PMCID： PMC8417141          DOI： 10.1136/annrheumdis-2021-220088

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  3 in total

Review 1.  Protracted severe COVID-19 pneumonia following rituximab treatment: caution needed.

Authors:  Dimitrios Daoussis; Lydia Leonidou; Christina Kalogeropoulou; Fotini Paliogianni; Argyrios Tzouvelekis
Journal:  Rheumatol Int       Date:  2021-08-19       Impact factor: 3.580

2.  Progression of COVID-19 in a Patient on Anti-CD20 Antibody Treatment: Case Report and Literature Review.

Authors:  Sebastian Burgener; Philippe Rochat; Günter Dollenmaier; Gabriel Benz; Andreas D Kistler; Rosamaria Fulchini
Journal:  Case Rep Infect Dis       Date:  2022-02-25

Review 3.  Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections).

Authors:  Cara D Varley; Kevin L Winthrop
Journal:  Curr Rheumatol Rep       Date:  2021-07-16       Impact factor: 4.592
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.